236 related articles for article (PubMed ID: 8819496)
1. Expression and modulation of 5-hydroxytryptamine1A receptors in P11 cells.
Hensler JG; Cervera LS; Miller HA; Corbitt J
J Pharmacol Exp Ther; 1996 Sep; 278(3):1138-45. PubMed ID: 8819496
[TBL] [Abstract][Full Text] [Related]
2. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
Yocca FD; Iben L; Meller E
Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034
[TBL] [Abstract][Full Text] [Related]
3. Effects of postmortem delay on serotonin and (+)8-OH-DPAT-mediated inhibition of adenylyl cyclase activity in rat and human brain tissues.
Palego L; Giromella A; Marazziti D; Borsini F; Naccarato AG; Giannaccini G; Lucacchini A; Cassano GB; Mazzoni MR
Brain Res; 1999 Jan; 816(1):165-74. PubMed ID: 9878719
[TBL] [Abstract][Full Text] [Related]
4. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
Pauwels PJ; Van Gompel P; Leysen JE
Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
[TBL] [Abstract][Full Text] [Related]
5. Agonist-induced desensitization and loss of high-affinity binding sites of stably expressed human 5-HT1A receptors.
Harrington MA; Shaw K; Zhong P; Ciaranello RD
J Pharmacol Exp Ther; 1994 Mar; 268(3):1098-106. PubMed ID: 8138923
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
7. Potential mechanisms involved in the negative coupling between serotonin 5-HT1A receptors and carbachol-stimulated phosphoinositide turnover in the rat hippocampus.
Claustre Y; Benavides J; Scatton B
J Neurochem; 1991 Apr; 56(4):1276-85. PubMed ID: 1848278
[TBL] [Abstract][Full Text] [Related]
8. Differential coupling of 5-HT1A receptors occupied by 5-HT or 8-OH-DPAT to adenylyl cyclase.
Varrault A; Bockaert J
Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):367-74. PubMed ID: 1436121
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic evidence for 5-HT1A receptors associated with human retinal pigment epithelial cells in culture.
Nash MS; Osborne NN
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):510-9. PubMed ID: 9040484
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
Dumuis A; Sebben M; Bockaert J
Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
[TBL] [Abstract][Full Text] [Related]
11. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
[TBL] [Abstract][Full Text] [Related]
12. 5-CT stimulation of adenylyl cyclase activity in guinea-pig hippocampus: evidence for involvement of 5-HT7 and 5-HT1A receptors.
Thomas DR; Middlemiss DN; Taylor SG; Nelson P; Brown AM
Br J Pharmacol; 1999 Sep; 128(1):158-64. PubMed ID: 10498847
[TBL] [Abstract][Full Text] [Related]
13. Ca2+ inhibition of beta-adrenergic receptor- and forskolin-stimulated cAMP accumulation in C6-2B rat glioma cells is independent of protein kinase C.
Debernardi MA; Munshi R; Brooker G
Mol Pharmacol; 1993 Mar; 43(3):451-8. PubMed ID: 8383803
[TBL] [Abstract][Full Text] [Related]
14. Cell-specific signaling of the 5-HT1A receptor. Modulation by protein kinases C and A.
Liu YF; Albert PR
J Biol Chem; 1991 Dec; 266(35):23689-97. PubMed ID: 1660881
[TBL] [Abstract][Full Text] [Related]
15. Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus.
Schoeffter P; Hoyer D
Br J Pharmacol; 1988 Nov; 95(3):975-85. PubMed ID: 3207999
[TBL] [Abstract][Full Text] [Related]
16. Native 5-HT1B receptors expressed in OK cells display dual coupling to elevation of intracellular calcium concentrations and inhibition of adenylate cyclase.
Zgombick JM; Branchek TA
Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):503-8. PubMed ID: 9840417
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
Khawaja X; Ennis C; Minchin MC
Life Sci; 1997; 60(9):653-65. PubMed ID: 9048968
[TBL] [Abstract][Full Text] [Related]
18. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors.
Clarke RW; Ogilvie J; Houghton AK
Br J Pharmacol; 1997 Oct; 122(4):631-8. PubMed ID: 9375958
[TBL] [Abstract][Full Text] [Related]
19. Partial agonist properties of rauwolscine and yohimbine for the inhibition of adenylyl cyclase by recombinant human 5-HT1A receptors.
Arthur JM; Casañas SJ; Raymond JR
Biochem Pharmacol; 1993 Jun; 45(11):2337-41. PubMed ID: 8517875
[TBL] [Abstract][Full Text] [Related]
20. Multiple phosphorylation sites are required for pathway-selective uncoupling of the 5-hydroxytryptamine1A receptor by protein kinase C.
Lembo PM; Albert PR
Mol Pharmacol; 1995 Dec; 48(6):1024-9. PubMed ID: 8848001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
